Adalimumab vs methotrexate for the treatment of chronic plaque psoriasis

Affiliations

Comment

Jonathan M Batchelor et al. Arch Dermatol. 2009 Jun.

. 2009 Jun;145(6):704-6; discussion 706.

doi: 10.1001/archdermatol.2009.104.

¹ Department of Dermatology, Addenbrooke's Hospital, Cambridge, England. jonathan.batchelor@addenbrookes.nhs.uk

No abstract available

Comment on

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).
Saurat JH, Stingl G, Dubertret L, Papp K, Langley RG, Ortonne JP, Unnebrink K, Kaul M, Camez A; CHAMPION Study Investigators. Saurat JH, et al. Br J Dermatol. 2008 Mar;158(3):558-66. doi: 10.1111/j.1365-2133.2007.08315.x. Epub 2007 Nov 28. Br J Dermatol. 2008. PMID: 18047523 Clinical Trial.